A Brain Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease

Cavernous angioma (CA) is a vascular pathology caused by loss of function in one of the 3 CA genes (CCM1, CCM2, and CCM3) that result in rho kinase (ROCK) activation. We investigated a novel ROCK2 selective inhibitor for the ability to reduce brain lesion formation, growth and maturation. We used ge...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Stroke Res
Main Authors: McKerracher, Lisa, Shenkar, Robert, Abbinanti, Matthew, Cao, Ying, Peiper, Amy, Liao, James K., Lightle, Rhonda, Moore, Thomas, Hobson, Nicholas, Gallione, Carol, Ruschel, Joerg, Koskimäki, Janne, Girard, Romuald, Rosen, Kenneth, Marchuk, Douglas, Awad, Issam
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7036327/
https://ncbi.nlm.nih.gov/pubmed/31446620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-019-00725-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares